Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years

Background: Increasing life expectancy increases breast cancer (BC) rates in elderly, where better health allows for improved tolerance of treatments. We assessed trends in BC incidence of tumor subtypes for women with focus on the elderly. Methods: Changes in BC incidence in women by age from 2012...

Full description

Saved in:
Bibliographic Details
Main Authors: Frederik K. Palshof, Lina S. Mørch, Maj-Britt R. Jensen, Hans H. Storm, Niels Kroman, Tove H.F. Tvedskov
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977624001917
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856937508274176
author Frederik K. Palshof
Lina S. Mørch
Maj-Britt R. Jensen
Hans H. Storm
Niels Kroman
Tove H.F. Tvedskov
author_facet Frederik K. Palshof
Lina S. Mørch
Maj-Britt R. Jensen
Hans H. Storm
Niels Kroman
Tove H.F. Tvedskov
author_sort Frederik K. Palshof
collection DOAJ
description Background: Increasing life expectancy increases breast cancer (BC) rates in elderly, where better health allows for improved tolerance of treatments. We assessed trends in BC incidence of tumor subtypes for women with focus on the elderly. Methods: Changes in BC incidence in women by age from 2012 to 2021 were assessed using data from the Nordic countries. We calculated the incidence of BC subtypes by age group using data from the Danish Breast Cancer Group (DBCG) database. We used generalized linear models assuming a Poisson distribution. Results: In the Nordic countries, 205 305 women were diagnosed with BC between 2012 and 2021. In Denmark, 50 858 BC patients were diagnosed between 2012 and 2022, identified with tumor characteristics. Incidence of BC among women aged 80+ increased significantly across the Nordic Countries, with 1.24 % per year (95 % CI: 0.07 %: 2.41 %). In Denmark, in the 80+ group, the ER+/HER2- subtype had the highest increase, with 1.98 % per year (95 % CI: 1.10 %: 2.87 %). Conclusion: Across the Nordic countries, incidence of BC in women aged 80+ increased. In Denmark, rising incidence of BC is driven by the ER+/HER2- subtype in the 80+ group, which has the best prognosis and gentle treatments. More elderly BC patients will require treatment and follow-up in the future.
format Article
id doaj-art-d276de83069e4c17bb7cdfcd01a71462
institution Kabale University
issn 1532-3080
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Breast
spelling doaj-art-d276de83069e4c17bb7cdfcd01a714622025-02-12T05:30:36ZengElsevierBreast1532-30802025-02-0179103860Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten yearsFrederik K. Palshof0Lina S. Mørch1Maj-Britt R. Jensen2Hans H. Storm3Niels Kroman4Tove H.F. Tvedskov5The Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark; Department of Breast Surgery, Gentofte Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark; Corresponding author. The Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark.The Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, DenmarkDanish Breast Cancer Group (DBCG), Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Strandboulevarden 49, 2100 Copenhagen Ø, DenmarkThe Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, DenmarkThe Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark; Department of Breast Surgery, Gentofte Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup, DenmarkDepartment of Breast Surgery, Gentofte Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup, DenmarkBackground: Increasing life expectancy increases breast cancer (BC) rates in elderly, where better health allows for improved tolerance of treatments. We assessed trends in BC incidence of tumor subtypes for women with focus on the elderly. Methods: Changes in BC incidence in women by age from 2012 to 2021 were assessed using data from the Nordic countries. We calculated the incidence of BC subtypes by age group using data from the Danish Breast Cancer Group (DBCG) database. We used generalized linear models assuming a Poisson distribution. Results: In the Nordic countries, 205 305 women were diagnosed with BC between 2012 and 2021. In Denmark, 50 858 BC patients were diagnosed between 2012 and 2022, identified with tumor characteristics. Incidence of BC among women aged 80+ increased significantly across the Nordic Countries, with 1.24 % per year (95 % CI: 0.07 %: 2.41 %). In Denmark, in the 80+ group, the ER+/HER2- subtype had the highest increase, with 1.98 % per year (95 % CI: 1.10 %: 2.87 %). Conclusion: Across the Nordic countries, incidence of BC in women aged 80+ increased. In Denmark, rising incidence of BC is driven by the ER+/HER2- subtype in the 80+ group, which has the best prognosis and gentle treatments. More elderly BC patients will require treatment and follow-up in the future.http://www.sciencedirect.com/science/article/pii/S0960977624001917Breast cancer subtypesEstrogen receptorHER2Incidence ratesAge groups
spellingShingle Frederik K. Palshof
Lina S. Mørch
Maj-Britt R. Jensen
Hans H. Storm
Niels Kroman
Tove H.F. Tvedskov
Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
Breast
Breast cancer subtypes
Estrogen receptor
HER2
Incidence rates
Age groups
title Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
title_full Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
title_fullStr Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
title_full_unstemmed Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
title_short Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
title_sort trends in breast cancer among elderly women development in estrogen and her2 subtypes in the last ten years
topic Breast cancer subtypes
Estrogen receptor
HER2
Incidence rates
Age groups
url http://www.sciencedirect.com/science/article/pii/S0960977624001917
work_keys_str_mv AT frederikkpalshof trendsinbreastcanceramongelderlywomendevelopmentinestrogenandher2subtypesinthelasttenyears
AT linasmørch trendsinbreastcanceramongelderlywomendevelopmentinestrogenandher2subtypesinthelasttenyears
AT majbrittrjensen trendsinbreastcanceramongelderlywomendevelopmentinestrogenandher2subtypesinthelasttenyears
AT hanshstorm trendsinbreastcanceramongelderlywomendevelopmentinestrogenandher2subtypesinthelasttenyears
AT nielskroman trendsinbreastcanceramongelderlywomendevelopmentinestrogenandher2subtypesinthelasttenyears
AT tovehftvedskov trendsinbreastcanceramongelderlywomendevelopmentinestrogenandher2subtypesinthelasttenyears